HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

President Clinton set to veto product liability act; measure passed Senate March 21.

This article was originally published in The Rose Sheet

Executive Summary

PRODUCT LIABILITY BILL CLEARS SENATE BY 59-40 VOTE on March 21; however, supporters of product liability reform fail to come up with the two-thirds vote necessary to override President Clinton's threatened veto of the legislation. The House is slated to discuss the measure, which emerged from a House-Senate conference committee on March 14, after Easter recess. After months of deliberation, the conference bill (HR 956) closely resembles the product liability legislation introduced in the Senate almost a year ago.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS002653

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel